Jakafi - Ruxolitinib 5 mg / 1 Tablet 60 Tablet
Reference details for licensed healthcare facility review and verification.
| NDC 11 | 50881-0005-60 |
|---|---|
| Product NDC | 50881-0005 |
| Generic Drug Name | ruxolitinib |
| Brand Name | Jakafi |
| Manufacturer | Incyte Corporation |
| Strength | 5 mg / 1 |
| Dosage Form | Tablet |
| Drug Type | Oral |
| Package Quantity | 60 Tablet |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (50881-005-60) |
| Active Ingredients | Ruxolitinib |
| Marketing Category | NDA |
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
NDC snapshot
ruxolitinib 5 mg / 1 Tablet is tracked under NDC 50881-0005-60 and rolls up into product family 50881-0005. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.
- Package configuration: 60 Tablet.
- Manufacturer: Incyte Corporation.
- Dosage form: Tablet.
- Family size: 1 indexed presentation.
Click a tag to refine the catalog view around this exact presentation.
Official references
Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.
Jakafi - Ruxolitinib 5 mg / 1 Tablet 60 Tablet, NDC 50881-0005-60, is a Incyte Corporation 5 mg / 1 tablet presentation packaged as 60 Tablet.
NDC search formats
- Canonical NDC 11: 50881-0005-60
- Digits-only NDC 11: 50881000560
- Possible 10-digit display format: 50881-005-60 (5088100560)
Helpful product links
- Search by brand name: Jakafi
- Exact NDC 11: 50881-0005-60
- Product family NDC: 50881-0005
- VA classification code: IM900
- VA classification code description: IMMUNOLOGICAL AGENTS,OTHER
- CMOP ID: R0295
- VUID: 4031232